nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupivacaine—CYP2D6—Fingolimod—multiple sclerosis	0.107	0.214	CbGbCtD
Bupivacaine—CYP3A4—Fingolimod—multiple sclerosis	0.0681	0.136	CbGbCtD
Bupivacaine—CYP2C19—Prednisone—multiple sclerosis	0.055	0.11	CbGbCtD
Bupivacaine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0439	0.0878	CbGbCtD
Bupivacaine—CYP2C19—Dexamethasone—multiple sclerosis	0.0343	0.0687	CbGbCtD
Bupivacaine—CYP3A4—Triamcinolone—multiple sclerosis	0.0333	0.0666	CbGbCtD
Bupivacaine—CYP3A4—Mitoxantrone—multiple sclerosis	0.032	0.0641	CbGbCtD
Bupivacaine—CYP3A4—Betamethasone—multiple sclerosis	0.0285	0.0571	CbGbCtD
Bupivacaine—CYP3A4—Prednisolone—multiple sclerosis	0.0282	0.0563	CbGbCtD
Bupivacaine—CYP3A4—Prednisone—multiple sclerosis	0.0266	0.0532	CbGbCtD
Bupivacaine—CYP2D6—Dexamethasone—multiple sclerosis	0.0261	0.0522	CbGbCtD
Bupivacaine—CYP3A4—Dexamethasone—multiple sclerosis	0.0166	0.0332	CbGbCtD
Bupivacaine—SCN10A—peripheral nervous system—multiple sclerosis	0.00205	0.239	CbGeAlD
Bupivacaine—SCN10A—nerve—multiple sclerosis	0.0016	0.186	CbGeAlD
Bupivacaine—PTGER1—nervous system—multiple sclerosis	0.000741	0.0862	CbGeAlD
Bupivacaine—PTGER1—central nervous system—multiple sclerosis	0.000713	0.083	CbGeAlD
Bupivacaine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00065	0.00699	CbGpPWpGaD
Bupivacaine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00065	0.00699	CbGpPWpGaD
Bupivacaine—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000642	0.0069	CbGpPWpGaD
Bupivacaine—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000642	0.0069	CbGpPWpGaD
Bupivacaine—PTGER1—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.00063	0.00677	CbGpPWpGaD
Bupivacaine—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000593	0.00637	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.00059	0.00634	CbGpPWpGaD
Bupivacaine—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000573	0.00616	CbGpPWpGaD
Bupivacaine—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000573	0.00616	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—S1PR1—multiple sclerosis	0.000558	0.00599	CbGpPWpGaD
Bupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000551	0.00592	CbGpPWpGaD
Bupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000551	0.00592	CbGpPWpGaD
Bupivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000544	0.00584	CbGpPWpGaD
Bupivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000544	0.00584	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00054	0.0058	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00054	0.0058	CbGpPWpGaD
Bupivacaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000527	0.00567	CbGpPWpGaD
Bupivacaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000527	0.00567	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000472	0.00508	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—PRNP—multiple sclerosis	0.000459	0.00493	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—GPR65—multiple sclerosis	0.00045	0.00483	CbGpPWpGaD
Bupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000447	0.0048	CbGpPWpGaD
Bupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000447	0.0048	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—PRNP—multiple sclerosis	0.000443	0.00476	CbGpPWpGaD
Bupivacaine—PTGER1—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.000432	0.00465	CbGpPWpGaD
Bupivacaine—SCN10A—spinal cord—multiple sclerosis	0.000427	0.0497	CbGeAlD
Bupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000425	0.00457	CbGpPWpGaD
Bupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000425	0.00457	CbGpPWpGaD
Bupivacaine—SCN4A—nervous system—multiple sclerosis	0.000422	0.0491	CbGeAlD
Bupivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00042	0.00451	CbGpPWpGaD
Bupivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00042	0.00451	CbGpPWpGaD
Bupivacaine—PTGER1—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000417	0.00449	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—CXCL13—multiple sclerosis	0.000411	0.00442	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—CCR1—multiple sclerosis	0.000411	0.00442	CbGpPWpGaD
Bupivacaine—SCN4A—central nervous system—multiple sclerosis	0.000406	0.0473	CbGeAlD
Bupivacaine—PTGER1—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000406	0.00436	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000385	0.00413	CbGpPWpGaD
Bupivacaine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000381	0.0041	CbGpPWpGaD
Bupivacaine—PTGER1—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.000375	0.00403	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00037	0.00398	CbGpPWpGaD
Bupivacaine—SCN10A—nervous system—multiple sclerosis	0.00036	0.0419	CbGeAlD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000358	0.00384	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—PTPRC—multiple sclerosis	0.000357	0.00384	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000348	0.00374	CbGpPWpGaD
Bupivacaine—SCN10A—central nervous system—multiple sclerosis	0.000347	0.0403	CbGeAlD
Bupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000345	0.0037	CbGpPWpGaD
Bupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000345	0.0037	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—PTPRC—multiple sclerosis	0.000344	0.0037	CbGpPWpGaD
Bupivacaine—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000331	0.00356	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—PRNP—multiple sclerosis	0.000328	0.00352	CbGpPWpGaD
Bupivacaine—SCN4A—brain—multiple sclerosis	0.000322	0.0375	CbGeAlD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000321	0.00345	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—PRNP—multiple sclerosis	0.000316	0.0034	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000315	0.00339	CbGpPWpGaD
Bupivacaine—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000305	0.00327	CbGpPWpGaD
Bupivacaine—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000304	0.00327	CbGpPWpGaD
Bupivacaine—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000304	0.00327	CbGpPWpGaD
Bupivacaine—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.0003	0.00323	CbGpPWpGaD
Bupivacaine—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.0003	0.00323	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000297	0.00319	CbGpPWpGaD
Bupivacaine—Bradycardia—Prednisone—multiple sclerosis	0.000294	0.000738	CcSEcCtD
Bupivacaine—PTGER1—GPCR ligand binding—CCL3—multiple sclerosis	0.000293	0.00315	CbGpPWpGaD
Bupivacaine—Diarrhoea—Azathioprine—multiple sclerosis	0.000291	0.000731	CcSEcCtD
Bupivacaine—Angioedema—Triamcinolone—multiple sclerosis	0.000291	0.000729	CcSEcCtD
Bupivacaine—Angioedema—Methylprednisolone—multiple sclerosis	0.00029	0.000728	CcSEcCtD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000289	0.00311	CbGpPWpGaD
Bupivacaine—Erythema—Dexamethasone—multiple sclerosis	0.000289	0.000724	CcSEcCtD
Bupivacaine—Erythema—Betamethasone—multiple sclerosis	0.000289	0.000724	CcSEcCtD
Bupivacaine—PTGER1—Signaling by GPCR—S1PR1—multiple sclerosis	0.000286	0.00308	CbGpPWpGaD
Bupivacaine—Syncope—Triamcinolone—multiple sclerosis	0.000285	0.000716	CcSEcCtD
Bupivacaine—Syncope—Methylprednisolone—multiple sclerosis	0.000285	0.000714	CcSEcCtD
Bupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000284	0.00305	CbGpPWpGaD
Bupivacaine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000284	0.000712	CcSEcCtD
Bupivacaine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000282	0.000708	CcSEcCtD
Bupivacaine—Oedema—Prednisolone—multiple sclerosis	0.000282	0.000708	CcSEcCtD
Bupivacaine—PTGER1—GPCR ligand binding—PTGER4—multiple sclerosis	0.000282	0.00303	CbGpPWpGaD
Bupivacaine—Dizziness—Azathioprine—multiple sclerosis	0.000282	0.000706	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000282	0.000706	CcSEcCtD
Bupivacaine—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.00028	0.00301	CbGpPWpGaD
Bupivacaine—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.00028	0.00301	CbGpPWpGaD
Bupivacaine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.00028	0.000702	CcSEcCtD
Bupivacaine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000279	0.0007	CcSEcCtD
Bupivacaine—Shock—Prednisolone—multiple sclerosis	0.000278	0.000697	CcSEcCtD
Bupivacaine—Cough—Triamcinolone—multiple sclerosis	0.000278	0.000697	CcSEcCtD
Bupivacaine—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000276	0.00297	CbGpPWpGaD
Bupivacaine—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000276	0.00297	CbGpPWpGaD
Bupivacaine—Convulsion—Triamcinolone—multiple sclerosis	0.000276	0.000692	CcSEcCtD
Bupivacaine—Tachycardia—Prednisolone—multiple sclerosis	0.000276	0.000691	CcSEcCtD
Bupivacaine—SCN10A—brain—multiple sclerosis	0.000275	0.032	CbGeAlD
Bupivacaine—Convulsion—Methylprednisolone—multiple sclerosis	0.000275	0.00069	CcSEcCtD
Bupivacaine—Hypertension—Triamcinolone—multiple sclerosis	0.000275	0.000689	CcSEcCtD
Bupivacaine—Hypertension—Methylprednisolone—multiple sclerosis	0.000274	0.000688	CcSEcCtD
Bupivacaine—Urticaria—Mitoxantrone—multiple sclerosis	0.000274	0.000686	CcSEcCtD
Bupivacaine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000273	0.000685	CcSEcCtD
Bupivacaine—PTGER1—GPCR ligand binding—CXCR3—multiple sclerosis	0.000272	0.00293	CbGpPWpGaD
Bupivacaine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000272	0.000683	CcSEcCtD
Bupivacaine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000272	0.000683	CcSEcCtD
Bupivacaine—Vomiting—Azathioprine—multiple sclerosis	0.000271	0.000679	CcSEcCtD
Bupivacaine—Arthralgia—Methylprednisolone—multiple sclerosis	0.00027	0.000678	CcSEcCtD
Bupivacaine—Anxiety—Methylprednisolone—multiple sclerosis	0.000269	0.000676	CcSEcCtD
Bupivacaine—SCN4A—L1CAM interactions—MAPK1—multiple sclerosis	0.000269	0.00289	CbGpPWpGaD
Bupivacaine—Infestation NOS—Methotrexate—multiple sclerosis	0.000269	0.000675	CcSEcCtD
Bupivacaine—Infestation—Methotrexate—multiple sclerosis	0.000269	0.000675	CcSEcCtD
Bupivacaine—Drowsiness—Methotrexate—multiple sclerosis	0.000269	0.000675	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000268	0.000673	CcSEcCtD
Bupivacaine—Flushing—Prednisone—multiple sclerosis	0.000268	0.000672	CcSEcCtD
Bupivacaine—PTGER1—GPCR downstream signaling—RGS1—multiple sclerosis	0.000268	0.00288	CbGpPWpGaD
Bupivacaine—Headache—Azathioprine—multiple sclerosis	0.000267	0.000669	CcSEcCtD
Bupivacaine—PTGER1—GPCR ligand binding—CCR2—multiple sclerosis	0.000265	0.00285	CbGpPWpGaD
Bupivacaine—Angioedema—Dexamethasone—multiple sclerosis	0.000264	0.000662	CcSEcCtD
Bupivacaine—Angioedema—Betamethasone—multiple sclerosis	0.000264	0.000662	CcSEcCtD
Bupivacaine—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000262	0.00282	CbGpPWpGaD
Bupivacaine—PTGER1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000262	0.00281	CbGpPWpGaD
Bupivacaine—Confusional state—Methylprednisolone—multiple sclerosis	0.000261	0.000655	CcSEcCtD
Bupivacaine—Oedema—Triamcinolone—multiple sclerosis	0.00026	0.000651	CcSEcCtD
Bupivacaine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00026	0.000651	CcSEcCtD
Bupivacaine—SCN10A—L1CAM interactions—MAPK1—multiple sclerosis	0.000259	0.00279	CbGpPWpGaD
Bupivacaine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000259	0.00065	CcSEcCtD
Bupivacaine—Syncope—Betamethasone—multiple sclerosis	0.000259	0.00065	CcSEcCtD
Bupivacaine—Syncope—Dexamethasone—multiple sclerosis	0.000259	0.00065	CcSEcCtD
Bupivacaine—Arrhythmia—Prednisone—multiple sclerosis	0.000258	0.000647	CcSEcCtD
Bupivacaine—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000258	0.00277	CbGpPWpGaD
Bupivacaine—Infection—Triamcinolone—multiple sclerosis	0.000258	0.000647	CcSEcCtD
Bupivacaine—Sweating—Methotrexate—multiple sclerosis	0.000258	0.000647	CcSEcCtD
Bupivacaine—Infection—Methylprednisolone—multiple sclerosis	0.000257	0.000646	CcSEcCtD
Bupivacaine—Haematuria—Methotrexate—multiple sclerosis	0.000256	0.000643	CcSEcCtD
Bupivacaine—Shock—Triamcinolone—multiple sclerosis	0.000256	0.000641	CcSEcCtD
Bupivacaine—Insomnia—Prednisolone—multiple sclerosis	0.000255	0.000641	CcSEcCtD
Bupivacaine—Shock—Methylprednisolone—multiple sclerosis	0.000255	0.00064	CcSEcCtD
Bupivacaine—SCN4A—Developmental Biology—PTPRC—multiple sclerosis	0.000255	0.00274	CbGpPWpGaD
Bupivacaine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000254	0.000637	CcSEcCtD
Bupivacaine—PTGER1—GPCR downstream signaling—GPR65—multiple sclerosis	0.000254	0.00273	CbGpPWpGaD
Bupivacaine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000254	0.000637	CcSEcCtD
Bupivacaine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000254	0.000637	CcSEcCtD
Bupivacaine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000254	0.000636	CcSEcCtD
Bupivacaine—Paraesthesia—Prednisolone—multiple sclerosis	0.000254	0.000636	CcSEcCtD
Bupivacaine—Tachycardia—Triamcinolone—multiple sclerosis	0.000254	0.000636	CcSEcCtD
Bupivacaine—Mental disorder—Prednisone—multiple sclerosis	0.000253	0.000635	CcSEcCtD
Bupivacaine—Nausea—Azathioprine—multiple sclerosis	0.000253	0.000634	CcSEcCtD
Bupivacaine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000253	0.000634	CcSEcCtD
Bupivacaine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000252	0.000631	CcSEcCtD
Bupivacaine—Malnutrition—Prednisone—multiple sclerosis	0.000251	0.000631	CcSEcCtD
Bupivacaine—Erythema—Prednisone—multiple sclerosis	0.000251	0.000631	CcSEcCtD
Bupivacaine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000251	0.00063	CcSEcCtD
Bupivacaine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000251	0.000628	CcSEcCtD
Bupivacaine—Convulsion—Dexamethasone—multiple sclerosis	0.00025	0.000628	CcSEcCtD
Bupivacaine—Convulsion—Betamethasone—multiple sclerosis	0.00025	0.000628	CcSEcCtD
Bupivacaine—Hypertension—Dexamethasone—multiple sclerosis	0.000249	0.000625	CcSEcCtD
Bupivacaine—Hypertension—Betamethasone—multiple sclerosis	0.000249	0.000625	CcSEcCtD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000249	0.00267	CbGpPWpGaD
Bupivacaine—Asthenia—Mitoxantrone—multiple sclerosis	0.000247	0.00062	CcSEcCtD
Bupivacaine—SCN10A—Developmental Biology—PTPRC—multiple sclerosis	0.000246	0.00264	CbGpPWpGaD
Bupivacaine—Anxiety—Dexamethasone—multiple sclerosis	0.000245	0.000614	CcSEcCtD
Bupivacaine—Anxiety—Betamethasone—multiple sclerosis	0.000245	0.000614	CcSEcCtD
Bupivacaine—PTGER1—GPCR ligand binding—CNR1—multiple sclerosis	0.000244	0.00263	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—RGS1—multiple sclerosis	0.000243	0.00262	CbGpPWpGaD
Bupivacaine—Hypotension—Methylprednisolone—multiple sclerosis	0.000242	0.000607	CcSEcCtD
Bupivacaine—Pain—Prednisolone—multiple sclerosis	0.000242	0.000606	CcSEcCtD
Bupivacaine—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000237	0.00255	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000237	0.00255	CbGpPWpGaD
Bupivacaine—Vision blurred—Prednisone—multiple sclerosis	0.000237	0.000594	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000237	0.000594	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000236	0.000592	CcSEcCtD
Bupivacaine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000236	0.000591	CcSEcCtD
Bupivacaine—Oedema—Dexamethasone—multiple sclerosis	0.000236	0.000591	CcSEcCtD
Bupivacaine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000236	0.000591	CcSEcCtD
Bupivacaine—Oedema—Betamethasone—multiple sclerosis	0.000236	0.000591	CcSEcCtD
Bupivacaine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000236	0.000591	CcSEcCtD
Bupivacaine—Insomnia—Triamcinolone—multiple sclerosis	0.000235	0.000589	CcSEcCtD
Bupivacaine—Insomnia—Methylprednisolone—multiple sclerosis	0.000234	0.000588	CcSEcCtD
Bupivacaine—CYP2D6—brainstem—multiple sclerosis	0.000234	0.0272	CbGeAlD
Bupivacaine—Infection—Dexamethasone—multiple sclerosis	0.000234	0.000587	CcSEcCtD
Bupivacaine—Infection—Betamethasone—multiple sclerosis	0.000234	0.000587	CcSEcCtD
Bupivacaine—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000234	0.00251	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000234	0.00251	CbGpPWpGaD
Bupivacaine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000233	0.000585	CcSEcCtD
Bupivacaine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000233	0.000584	CcSEcCtD
Bupivacaine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000233	0.000584	CcSEcCtD
Bupivacaine—Anaemia—Prednisone—multiple sclerosis	0.000232	0.000583	CcSEcCtD
Bupivacaine—PTGER1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000232	0.0025	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000232	0.0025	CbGpPWpGaD
Bupivacaine—Shock—Dexamethasone—multiple sclerosis	0.000232	0.000582	CcSEcCtD
Bupivacaine—Shock—Betamethasone—multiple sclerosis	0.000232	0.000582	CcSEcCtD
Bupivacaine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000232	0.000581	CcSEcCtD
Bupivacaine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000231	0.00058	CcSEcCtD
Bupivacaine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000231	0.00058	CcSEcCtD
Bupivacaine—Agitation—Prednisone—multiple sclerosis	0.000231	0.00058	CcSEcCtD
Bupivacaine—PTGER1—Signaling by GPCR—GPR65—multiple sclerosis	0.000231	0.00248	CbGpPWpGaD
Bupivacaine—Tachycardia—Dexamethasone—multiple sclerosis	0.00023	0.000577	CcSEcCtD
Bupivacaine—Tachycardia—Betamethasone—multiple sclerosis	0.00023	0.000577	CcSEcCtD
Bupivacaine—Angioedema—Prednisone—multiple sclerosis	0.00023	0.000576	CcSEcCtD
Bupivacaine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000229	0.000573	CcSEcCtD
Bupivacaine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000228	0.000572	CcSEcCtD
Bupivacaine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000228	0.000571	CcSEcCtD
Bupivacaine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000228	0.000571	CcSEcCtD
Bupivacaine—Syncope—Prednisone—multiple sclerosis	0.000226	0.000566	CcSEcCtD
Bupivacaine—Tinnitus—Methotrexate—multiple sclerosis	0.000225	0.000565	CcSEcCtD
Bupivacaine—Urticaria—Prednisolone—multiple sclerosis	0.000224	0.000563	CcSEcCtD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000224	0.00241	CbGpPWpGaD
Bupivacaine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000224	0.000562	CcSEcCtD
Bupivacaine—PTGER1—Signaling Pathways—LINGO1—multiple sclerosis	0.000223	0.0024	CbGpPWpGaD
Bupivacaine—Pain—Triamcinolone—multiple sclerosis	0.000222	0.000557	CcSEcCtD
Bupivacaine—Loss of consciousness—Prednisone—multiple sclerosis	0.000221	0.000554	CcSEcCtD
Bupivacaine—Hypotension—Betamethasone—multiple sclerosis	0.00022	0.000552	CcSEcCtD
Bupivacaine—Hypotension—Dexamethasone—multiple sclerosis	0.00022	0.000552	CcSEcCtD
Bupivacaine—PTGER1—GPCR ligand binding—CXCL10—multiple sclerosis	0.00022	0.00237	CbGpPWpGaD
Bupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000219	0.00236	CbGpPWpGaD
Bupivacaine—Vomiting—Mitoxantrone—multiple sclerosis	0.000219	0.000549	CcSEcCtD
Bupivacaine—Convulsion—Prednisone—multiple sclerosis	0.000218	0.000546	CcSEcCtD
Bupivacaine—Hypertension—Prednisone—multiple sclerosis	0.000217	0.000545	CcSEcCtD
Bupivacaine—Chills—Methotrexate—multiple sclerosis	0.000217	0.000543	CcSEcCtD
Bupivacaine—Headache—Mitoxantrone—multiple sclerosis	0.000216	0.000541	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000215	0.000539	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000215	0.000539	CcSEcCtD
Bupivacaine—Arthralgia—Prednisone—multiple sclerosis	0.000214	0.000537	CcSEcCtD
Bupivacaine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000214	0.000537	CcSEcCtD
Bupivacaine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000214	0.000536	CcSEcCtD
Bupivacaine—Anxiety—Prednisone—multiple sclerosis	0.000213	0.000535	CcSEcCtD
Bupivacaine—Insomnia—Dexamethasone—multiple sclerosis	0.000213	0.000535	CcSEcCtD
Bupivacaine—Insomnia—Betamethasone—multiple sclerosis	0.000213	0.000535	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000213	0.000533	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000212	0.000532	CcSEcCtD
Bupivacaine—Paraesthesia—Betamethasone—multiple sclerosis	0.000212	0.000531	CcSEcCtD
Bupivacaine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000212	0.000531	CcSEcCtD
Bupivacaine—Mental disorder—Methotrexate—multiple sclerosis	0.000212	0.000531	CcSEcCtD
Bupivacaine—PTGER1—Signaling by GPCR—CCR1—multiple sclerosis	0.000211	0.00227	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000211	0.00227	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.00021	0.00226	CbGpPWpGaD
Bupivacaine—Malnutrition—Methotrexate—multiple sclerosis	0.00021	0.000527	CcSEcCtD
Bupivacaine—Erythema—Methotrexate—multiple sclerosis	0.00021	0.000527	CcSEcCtD
Bupivacaine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000208	0.000522	CcSEcCtD
Bupivacaine—Dyspepsia—Betamethasone—multiple sclerosis	0.000207	0.00052	CcSEcCtD
Bupivacaine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000207	0.00052	CcSEcCtD
Bupivacaine—Urticaria—Triamcinolone—multiple sclerosis	0.000206	0.000518	CcSEcCtD
Bupivacaine—Urticaria—Methylprednisolone—multiple sclerosis	0.000206	0.000516	CcSEcCtD
Bupivacaine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000205	0.000515	CcSEcCtD
Bupivacaine—Oedema—Prednisone—multiple sclerosis	0.000205	0.000515	CcSEcCtD
Bupivacaine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000205	0.000515	CcSEcCtD
Bupivacaine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000205	0.000514	CcSEcCtD
Bupivacaine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000205	0.000514	CcSEcCtD
Bupivacaine—Decreased appetite—Betamethasone—multiple sclerosis	0.000205	0.000514	CcSEcCtD
Bupivacaine—Nausea—Mitoxantrone—multiple sclerosis	0.000205	0.000513	CcSEcCtD
Bupivacaine—Infection—Prednisone—multiple sclerosis	0.000204	0.000511	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000203	0.00051	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000203	0.00051	CcSEcCtD
Bupivacaine—Back pain—Methotrexate—multiple sclerosis	0.000203	0.00051	CcSEcCtD
Bupivacaine—Shock—Prednisone—multiple sclerosis	0.000202	0.000506	CcSEcCtD
Bupivacaine—Pain—Betamethasone—multiple sclerosis	0.000202	0.000505	CcSEcCtD
Bupivacaine—Pain—Dexamethasone—multiple sclerosis	0.000202	0.000505	CcSEcCtD
Bupivacaine—Nervous system disorder—Prednisone—multiple sclerosis	0.000201	0.000505	CcSEcCtD
Bupivacaine—Tachycardia—Prednisone—multiple sclerosis	0.0002	0.000502	CcSEcCtD
Bupivacaine—Skin disorder—Prednisone—multiple sclerosis	0.000199	0.0005	CcSEcCtD
Bupivacaine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000198	0.000498	CcSEcCtD
Bupivacaine—Vision blurred—Methotrexate—multiple sclerosis	0.000198	0.000497	CcSEcCtD
Bupivacaine—Anaemia—Methotrexate—multiple sclerosis	0.000194	0.000487	CcSEcCtD
Bupivacaine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000194	0.000487	CcSEcCtD
Bupivacaine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000194	0.000487	CcSEcCtD
Bupivacaine—PTGER1—Signaling Pathways—TAGAP—multiple sclerosis	0.000193	0.00208	CbGpPWpGaD
Bupivacaine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000193	0.000483	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000193	0.000483	CcSEcCtD
Bupivacaine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000191	0.00048	CcSEcCtD
Bupivacaine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000191	0.000479	CcSEcCtD
Bupivacaine—PTGER1—GPCR ligand binding—CCL5—multiple sclerosis	0.000189	0.00204	CbGpPWpGaD
Bupivacaine—Urticaria—Dexamethasone—multiple sclerosis	0.000187	0.00047	CcSEcCtD
Bupivacaine—Urticaria—Betamethasone—multiple sclerosis	0.000187	0.00047	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000187	0.000469	CcSEcCtD
Bupivacaine—Dizziness—Prednisolone—multiple sclerosis	0.000187	0.000468	CcSEcCtD
Bupivacaine—Asthenia—Triamcinolone—multiple sclerosis	0.000186	0.000467	CcSEcCtD
Bupivacaine—Abdominal pain—Betamethasone—multiple sclerosis	0.000186	0.000467	CcSEcCtD
Bupivacaine—Body temperature increased—Betamethasone—multiple sclerosis	0.000186	0.000467	CcSEcCtD
Bupivacaine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000186	0.000467	CcSEcCtD
Bupivacaine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000186	0.000467	CcSEcCtD
Bupivacaine—Asthenia—Methylprednisolone—multiple sclerosis	0.000186	0.000466	CcSEcCtD
Bupivacaine—Insomnia—Prednisone—multiple sclerosis	0.000186	0.000466	CcSEcCtD
Bupivacaine—Paraesthesia—Prednisone—multiple sclerosis	0.000184	0.000462	CcSEcCtD
Bupivacaine—Pruritus—Triamcinolone—multiple sclerosis	0.000184	0.000461	CcSEcCtD
Bupivacaine—Cough—Methotrexate—multiple sclerosis	0.000183	0.00046	CcSEcCtD
Bupivacaine—Pruritus—Methylprednisolone—multiple sclerosis	0.000183	0.00046	CcSEcCtD
Bupivacaine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000183	0.00197	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000183	0.00197	CbGpPWpGaD
Bupivacaine—Convulsion—Methotrexate—multiple sclerosis	0.000182	0.000457	CcSEcCtD
Bupivacaine—Dyspepsia—Prednisone—multiple sclerosis	0.000181	0.000453	CcSEcCtD
Bupivacaine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000181	0.00194	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000181	0.00194	CbGpPWpGaD
Bupivacaine—Arthralgia—Methotrexate—multiple sclerosis	0.000179	0.000449	CcSEcCtD
Bupivacaine—Decreased appetite—Prednisone—multiple sclerosis	0.000178	0.000447	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000178	0.000446	CcSEcCtD
Bupivacaine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000177	0.000445	CcSEcCtD
Bupivacaine—Headache—Prednisolone—multiple sclerosis	0.000177	0.000444	CcSEcCtD
Bupivacaine—Constipation—Prednisone—multiple sclerosis	0.000176	0.00044	CcSEcCtD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000175	0.00188	CbGpPWpGaD
Bupivacaine—Confusional state—Methotrexate—multiple sclerosis	0.000173	0.000434	CcSEcCtD
Bupivacaine—Dizziness—Triamcinolone—multiple sclerosis	0.000172	0.000431	CcSEcCtD
Bupivacaine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000172	0.00043	CcSEcCtD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000171	0.00184	CbGpPWpGaD
Bupivacaine—Dizziness—Methylprednisolone—multiple sclerosis	0.000171	0.00043	CcSEcCtD
Bupivacaine—PTGER1—GPCR ligand binding—CCR5—multiple sclerosis	0.000171	0.00183	CbGpPWpGaD
Bupivacaine—Infection—Methotrexate—multiple sclerosis	0.00017	0.000427	CcSEcCtD
Bupivacaine—Feeling abnormal—Prednisone—multiple sclerosis	0.000169	0.000424	CcSEcCtD
Bupivacaine—Asthenia—Dexamethasone—multiple sclerosis	0.000169	0.000424	CcSEcCtD
Bupivacaine—Asthenia—Betamethasone—multiple sclerosis	0.000169	0.000424	CcSEcCtD
Bupivacaine—PTGER1—Signaling Pathways—S1PR1—multiple sclerosis	0.000169	0.00182	CbGpPWpGaD
Bupivacaine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000168	0.000422	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000168	0.000421	CcSEcCtD
Bupivacaine—Nausea—Prednisolone—multiple sclerosis	0.000168	0.000421	CcSEcCtD
Bupivacaine—Pruritus—Dexamethasone—multiple sclerosis	0.000167	0.000418	CcSEcCtD
Bupivacaine—Pruritus—Betamethasone—multiple sclerosis	0.000167	0.000418	CcSEcCtD
Bupivacaine—Skin disorder—Methotrexate—multiple sclerosis	0.000167	0.000418	CcSEcCtD
Bupivacaine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000166	0.000416	CcSEcCtD
Bupivacaine—Vomiting—Triamcinolone—multiple sclerosis	0.000165	0.000414	CcSEcCtD
Bupivacaine—Vomiting—Methylprednisolone—multiple sclerosis	0.000165	0.000413	CcSEcCtD
Bupivacaine—PTGER1—Signaling Pathways—GPC5—multiple sclerosis	0.000164	0.00177	CbGpPWpGaD
Bupivacaine—Urticaria—Prednisone—multiple sclerosis	0.000163	0.000409	CcSEcCtD
Bupivacaine—Headache—Triamcinolone—multiple sclerosis	0.000163	0.000408	CcSEcCtD
Bupivacaine—Headache—Methylprednisolone—multiple sclerosis	0.000162	0.000407	CcSEcCtD
Bupivacaine—Abdominal pain—Prednisone—multiple sclerosis	0.000162	0.000407	CcSEcCtD
Bupivacaine—Body temperature increased—Prednisone—multiple sclerosis	0.000162	0.000407	CcSEcCtD
Bupivacaine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000161	0.000404	CcSEcCtD
Bupivacaine—Diarrhoea—Betamethasone—multiple sclerosis	0.000161	0.000404	CcSEcCtD
Bupivacaine—Hypotension—Methotrexate—multiple sclerosis	0.00016	0.000402	CcSEcCtD
Bupivacaine—SCN4A—Axon guidance—TYK2—multiple sclerosis	0.00016	0.00172	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000159	0.00171	CbGpPWpGaD
Bupivacaine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000159	0.00171	CbGpPWpGaD
Bupivacaine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000156	0.000392	CcSEcCtD
Bupivacaine—Dizziness—Dexamethasone—multiple sclerosis	0.000156	0.000391	CcSEcCtD
Bupivacaine—Dizziness—Betamethasone—multiple sclerosis	0.000156	0.000391	CcSEcCtD
Bupivacaine—Insomnia—Methotrexate—multiple sclerosis	0.000155	0.000389	CcSEcCtD
Bupivacaine—Nausea—Triamcinolone—multiple sclerosis	0.000154	0.000387	CcSEcCtD
Bupivacaine—Paraesthesia—Methotrexate—multiple sclerosis	0.000154	0.000386	CcSEcCtD
Bupivacaine—SCN10A—Axon guidance—TYK2—multiple sclerosis	0.000154	0.00166	CbGpPWpGaD
Bupivacaine—Nausea—Methylprednisolone—multiple sclerosis	0.000154	0.000386	CcSEcCtD
Bupivacaine—PTGER1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000154	0.00165	CbGpPWpGaD
Bupivacaine—Dyspnoea—Methotrexate—multiple sclerosis	0.000153	0.000384	CcSEcCtD
Bupivacaine—Somnolence—Methotrexate—multiple sclerosis	0.000152	0.000382	CcSEcCtD
Bupivacaine—Hypersensitivity—Prednisone—multiple sclerosis	0.000151	0.000379	CcSEcCtD
Bupivacaine—Dyspepsia—Methotrexate—multiple sclerosis	0.000151	0.000379	CcSEcCtD
Bupivacaine—PTGER1—Signaling by GPCR—CCL3—multiple sclerosis	0.00015	0.00162	CbGpPWpGaD
Bupivacaine—Vomiting—Dexamethasone—multiple sclerosis	0.00015	0.000376	CcSEcCtD
Bupivacaine—Vomiting—Betamethasone—multiple sclerosis	0.00015	0.000376	CcSEcCtD
Bupivacaine—PTGER1—GPCR downstream signaling—CCR2—multiple sclerosis	0.00015	0.00161	CbGpPWpGaD
Bupivacaine—Decreased appetite—Methotrexate—multiple sclerosis	0.000149	0.000374	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000148	0.000371	CcSEcCtD
Bupivacaine—Headache—Dexamethasone—multiple sclerosis	0.000148	0.00037	CcSEcCtD
Bupivacaine—Headache—Betamethasone—multiple sclerosis	0.000148	0.00037	CcSEcCtD
Bupivacaine—Asthenia—Prednisone—multiple sclerosis	0.000147	0.000369	CcSEcCtD
Bupivacaine—Pain—Methotrexate—multiple sclerosis	0.000147	0.000368	CcSEcCtD
Bupivacaine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000146	0.00157	CbGpPWpGaD
Bupivacaine—Pruritus—Prednisone—multiple sclerosis	0.000145	0.000364	CcSEcCtD
Bupivacaine—PTGER1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000145	0.00156	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—RGS1—multiple sclerosis	0.000144	0.00155	CbGpPWpGaD
Bupivacaine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000141	0.000355	CcSEcCtD
Bupivacaine—Diarrhoea—Prednisone—multiple sclerosis	0.00014	0.000352	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.00014	0.000352	CcSEcCtD
Bupivacaine—Nausea—Dexamethasone—multiple sclerosis	0.00014	0.000351	CcSEcCtD
Bupivacaine—Nausea—Betamethasone—multiple sclerosis	0.00014	0.000351	CcSEcCtD
Bupivacaine—PTGER1—Signaling by GPCR—CXCR3—multiple sclerosis	0.00014	0.0015	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000138	0.00149	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—GPR65—multiple sclerosis	0.000136	0.00146	CbGpPWpGaD
Bupivacaine—Urticaria—Methotrexate—multiple sclerosis	0.000136	0.000342	CcSEcCtD
Bupivacaine—PTGER1—Signaling by GPCR—CCR2—multiple sclerosis	0.000136	0.00146	CbGpPWpGaD
Bupivacaine—Dizziness—Prednisone—multiple sclerosis	0.000136	0.00034	CcSEcCtD
Bupivacaine—Body temperature increased—Methotrexate—multiple sclerosis	0.000136	0.00034	CcSEcCtD
Bupivacaine—Abdominal pain—Methotrexate—multiple sclerosis	0.000136	0.00034	CcSEcCtD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000134	0.00144	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—POMC—multiple sclerosis	0.000133	0.00143	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—CCL2—multiple sclerosis	0.000131	0.0014	CbGpPWpGaD
Bupivacaine—Vomiting—Prednisone—multiple sclerosis	0.000131	0.000327	CcSEcCtD
Bupivacaine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000129	0.00139	CbGpPWpGaD
Bupivacaine—Headache—Prednisone—multiple sclerosis	0.000129	0.000322	CcSEcCtD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000128	0.00137	CbGpPWpGaD
Bupivacaine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000126	0.000317	CcSEcCtD
Bupivacaine—SCN4A—Axon guidance—MMP9—multiple sclerosis	0.000126	0.00135	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—CNR1—multiple sclerosis	0.000125	0.00135	CbGpPWpGaD
Bupivacaine—CYP3A4—nervous system—multiple sclerosis	0.000125	0.0145	CbGeAlD
Bupivacaine—PTGER1—Signaling Pathways—CXCL13—multiple sclerosis	0.000125	0.00134	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CCR1—multiple sclerosis	0.000125	0.00134	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000124	0.00134	CbGpPWpGaD
Bupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000124	0.00133	CbGpPWpGaD
Bupivacaine—Asthenia—Methotrexate—multiple sclerosis	0.000123	0.000309	CcSEcCtD
Bupivacaine—CYP2D6—nervous system—multiple sclerosis	0.000123	0.0143	CbGeAlD
Bupivacaine—Nausea—Prednisone—multiple sclerosis	0.000122	0.000306	CcSEcCtD
Bupivacaine—Pruritus—Methotrexate—multiple sclerosis	0.000121	0.000304	CcSEcCtD
Bupivacaine—SCN10A—Axon guidance—MMP9—multiple sclerosis	0.000121	0.0013	CbGpPWpGaD
Bupivacaine—CYP3A4—central nervous system—multiple sclerosis	0.00012	0.014	CbGeAlD
Bupivacaine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000119	0.00127	CbGpPWpGaD
Bupivacaine—CYP2D6—central nervous system—multiple sclerosis	0.000118	0.0137	CbGeAlD
Bupivacaine—Diarrhoea—Methotrexate—multiple sclerosis	0.000117	0.000294	CcSEcCtD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000117	0.00126	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000117	0.00126	CbGpPWpGaD
Bupivacaine—CYP2D6—cerebellum—multiple sclerosis	0.000115	0.0134	CbGeAlD
Bupivacaine—SCN4A—Developmental Biology—TYK2—multiple sclerosis	0.000114	0.00123	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.000114	0.00122	CbGpPWpGaD
Bupivacaine—Dizziness—Methotrexate—multiple sclerosis	0.000113	0.000284	CcSEcCtD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000113	0.00122	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000113	0.00121	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—TYK2—multiple sclerosis	0.00011	0.00118	CbGpPWpGaD
Bupivacaine—Vomiting—Methotrexate—multiple sclerosis	0.000109	0.000274	CcSEcCtD
Bupivacaine—Headache—Methotrexate—multiple sclerosis	0.000107	0.00027	CcSEcCtD
Bupivacaine—PTGER1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000107	0.00115	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000103	0.00111	CbGpPWpGaD
Bupivacaine—Nausea—Methotrexate—multiple sclerosis	0.000102	0.000256	CcSEcCtD
Bupivacaine—SCN4A—Axon guidance—MAPK1—multiple sclerosis	0.000102	0.00109	CbGpPWpGaD
Bupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.0001	0.00108	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—MAPK1—multiple sclerosis	9.8e-05	0.00105	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—CCL5—multiple sclerosis	9.72e-05	0.00105	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—CCR5—multiple sclerosis	9.65e-05	0.00104	CbGpPWpGaD
Bupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.56e-05	0.00103	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—IL2RA—multiple sclerosis	9.51e-05	0.00102	CbGpPWpGaD
Bupivacaine—CYP2D6—brain—multiple sclerosis	9.38e-05	0.0109	CbGeAlD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.11e-05	0.000979	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.11e-05	0.000979	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—MMP9—multiple sclerosis	8.98e-05	0.000965	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CCL3—multiple sclerosis	8.88e-05	0.000955	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	8.86e-05	0.000952	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	8.84e-05	0.00095	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—CCR5—multiple sclerosis	8.76e-05	0.000942	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	8.67e-05	0.000932	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—MMP9—multiple sclerosis	8.66e-05	0.00093	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—IL2RA—multiple sclerosis	8.63e-05	0.000928	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PTGER4—multiple sclerosis	8.55e-05	0.000919	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PGR—multiple sclerosis	8.42e-05	0.000905	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CXCR3—multiple sclerosis	8.26e-05	0.000887	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	8.25e-05	0.000887	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	8.25e-05	0.000887	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CD28—multiple sclerosis	8.18e-05	0.000879	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CCR2—multiple sclerosis	8.03e-05	0.000863	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—STAT3—multiple sclerosis	7.98e-05	0.000858	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—IL6—multiple sclerosis	7.81e-05	0.00084	CbGpPWpGaD
Bupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.75e-05	0.000833	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—STAT3—multiple sclerosis	7.7e-05	0.000827	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—POMC—multiple sclerosis	7.54e-05	0.00081	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—IL6—multiple sclerosis	7.53e-05	0.00081	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CNR1—multiple sclerosis	7.41e-05	0.000797	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—TGFB1—multiple sclerosis	7.4e-05	0.000795	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—SRM—multiple sclerosis	7.39e-05	0.000794	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—MAPK1—multiple sclerosis	7.26e-05	0.00078	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—TGFB1—multiple sclerosis	7.13e-05	0.000767	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—MAPK1—multiple sclerosis	7e-05	0.000752	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—TNF—multiple sclerosis	6.91e-05	0.000743	CbGpPWpGaD
Bupivacaine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	6.85e-05	0.000736	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—POMC—multiple sclerosis	6.85e-05	0.000736	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—SRM—multiple sclerosis	6.8e-05	0.000731	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—CCL2—multiple sclerosis	6.7e-05	0.00072	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CXCL10—multiple sclerosis	6.67e-05	0.000717	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—TNF—multiple sclerosis	6.66e-05	0.000716	CbGpPWpGaD
Bupivacaine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	6.3e-05	0.000677	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—TYK2—multiple sclerosis	6.08e-05	0.000654	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CD86—multiple sclerosis	5.84e-05	0.000627	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—SRM—multiple sclerosis	5.76e-05	0.000619	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CCL5—multiple sclerosis	5.74e-05	0.000617	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—IL6—multiple sclerosis	5.58e-05	0.000599	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—IL2—multiple sclerosis	5.57e-05	0.000599	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—IL6—multiple sclerosis	5.38e-05	0.000578	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	5.34e-05	0.000574	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SPP1—multiple sclerosis	5.32e-05	0.000572	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	5.21e-05	0.00056	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	5.21e-05	0.00056	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CCR5—multiple sclerosis	5.18e-05	0.000556	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IL2RA—multiple sclerosis	5.1e-05	0.000548	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.09e-05	0.000547	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—IL2—multiple sclerosis	5.06e-05	0.000544	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	4.79e-05	0.000515	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	4.79e-05	0.000515	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GPC5—multiple sclerosis	4.76e-05	0.000512	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—APOE—multiple sclerosis	4.71e-05	0.000506	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SRM—multiple sclerosis	4.44e-05	0.000478	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GPC5—multiple sclerosis	4.38e-05	0.000471	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CD80—multiple sclerosis	4.26e-05	0.000458	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	4.12e-05	0.000443	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	4.06e-05	0.000436	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	4.06e-05	0.000436	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—POMC—multiple sclerosis	4.04e-05	0.000435	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.97e-05	0.000426	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CCL2—multiple sclerosis	3.96e-05	0.000425	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—RRM1—multiple sclerosis	3.95e-05	0.000424	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—MAPK1—multiple sclerosis	3.87e-05	0.000416	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GPC5—multiple sclerosis	3.71e-05	0.000399	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.63e-05	0.00039	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TYK2—multiple sclerosis	3.59e-05	0.000386	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	3.13e-05	0.000337	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	3.13e-05	0.000337	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—RRM1—multiple sclerosis	3.07e-05	0.00033	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.06e-05	0.000329	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IL2—multiple sclerosis	2.99e-05	0.000321	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—IL6—multiple sclerosis	2.98e-05	0.00032	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.86e-05	0.000308	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MMP9—multiple sclerosis	2.83e-05	0.000304	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.63e-05	0.000283	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—STAT3—multiple sclerosis	2.52e-05	0.00027	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.4e-05	0.000258	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.39e-05	0.000256	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.37e-05	0.000255	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MYC—multiple sclerosis	2.34e-05	0.000251	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TGFB1—multiple sclerosis	2.33e-05	0.000251	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MAPK1—multiple sclerosis	2.29e-05	0.000246	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—BCHE—multiple sclerosis	2.27e-05	0.000244	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—BCHE—multiple sclerosis	2.08e-05	0.000224	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.05e-05	0.00022	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.87e-05	0.000201	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.77e-05	0.00019	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IL6—multiple sclerosis	1.76e-05	0.000189	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—APOE—multiple sclerosis	1.36e-05	0.000147	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.36e-05	0.000146	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—APOE—multiple sclerosis	1.25e-05	0.000135	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—POMC—multiple sclerosis	1.17e-05	0.000126	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—POMC—multiple sclerosis	1.08e-05	0.000116	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ALB—multiple sclerosis	1.07e-05	0.000115	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—APOE—multiple sclerosis	1.06e-05	0.000114	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ALB—multiple sclerosis	9.82e-06	0.000106	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—POMC—multiple sclerosis	9.13e-06	9.81e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ALB—multiple sclerosis	8.32e-06	8.94e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—APOE—multiple sclerosis	8.2e-06	8.81e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—POMC—multiple sclerosis	7.04e-06	7.57e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ALB—multiple sclerosis	6.42e-06	6.9e-05	CbGpPWpGaD
